Omnicell, Inc. (OMCL)

CIK 0000926326 · Healthcare · Health Information Services

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-07-30) · 99.1
Q1-2026 8-K (2026-04-28) · 99.1
Latest FY-2025 8-K (2026-02-05) · 99.1
Q3-2025 8-K (2025-10-30) · 99.1
Q2-2025 8-K (2025-07-31) · 99.1
Q1-2025 8-K (2025-05-06) · 99.1
FY-2024 8-K (2025-02-06) · 99.1 · 99.2
Q3-2024 8-K (2024-10-30) · 99.1
Q2-2024 8-K (2024-08-01) · 99.1
Q1-2024 8-K (2024-05-02) · 99.1
FY-2023 8-K (2024-02-08) · 99.1
Q3-2023 8-K (2023-11-02) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive Income (unaudited)
—
Condensed Consolidated Statements of Comprehensive Loss (unaudited)
—
Consolidated Statements of Comprehensive Income (loss)
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
—
Notes
Balance Sheet Components
Business Combinations
—
Cash and Cash Equivalents and Fair Value of Financial Instruments
—
Commitments and Contingencies
Convertible Senior Notes
Cybersecurity Risk Management and Strategy Disclosure
—
Debt and Credit Agreement
Employee Benefits and Share-based Compensation
External-use Software Development Costs
Fair Value of Financial Instruments
—
Goodwill and Intangible Assets
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Lessee Leases
Lessor Leases
Net Income (loss) Per Share
Net Loss Per Share
—
Organization and Summary of Significant Accounting Policies
Pay Vs Performance Disclosure
Property and Equipment
Restructuring Expenses
Revenues
Schedule Ii Valuation and Qualifying Accounts
—
Segment Information
Stock Repurchase Programs
—
Subsequent Events
—